← Back to home

RECURRENT EPITHELIAL OVARIAN CANCER WHICH INCLUDES EPITHELIAL OVARIAN, FALLOPIAN TUBE AND/OR PRIMARY PERITONEAL CANCER

Clinical trials for RECURRENT EPITHELIAL OVARIAN CANCER WHICH INCLUDES EPITHELIAL OVARIAN, FALLOPIAN TUBE AND/OR PRIMARY PERITONEAL CANCER explained in plain language.

Never miss a new study

Get alerted when new RECURRENT EPITHELIAL OVARIAN CANCER WHICH INCLUDES EPITHELIAL OVARIAN, FALLOPIAN TUBE AND/OR PRIMARY PERITONEAL CANCER trials appear

Sign up with your email to follow new studies for RECURRENT EPITHELIAL OVARIAN CANCER WHICH INCLUDES EPITHELIAL OVARIAN, FALLOPIAN TUBE AND/OR PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test custom cancer vaccine made from Patient's own tumor

Disease control Recruiting now

This is an early, small study to see if a personalized cell-based vaccine is safe and can trigger an immune response in patients with recurrent ovarian cancer. Doctors will take a sample of the patient's tumor to create a custom vaccine, which is then injected back into the patie…

Matched conditions: RECURRENT EPITHELIAL OVARIAN CANCER WHICH INCLUDES EPITHELIAL OVARIAN, FALLOPIAN TUBE AND/OR PRIMARY PERITONEAL CANCER

Phase: PHASE1 • Sponsor: PhotonPharma, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

RECURRENT EPITHELIAL OVARIAN CANCER WHICH INCLUDES EPITHELIAL OVARIAN, FALLOPIAN TUBE AND/OR PRIMARY PERITONEAL CANCER

Get alerted when new RECURRENT EPITHELIAL OVARIAN CANCER WHICH INCLUDES EPITHELIAL OVARIAN, FALLOPIAN TUBE AND/OR PRIMARY PERITONEAL CANCER trials appear

Scientists test custom cancer vaccine made from Patient's own tumor